Accelerating Time-to-Market: EDC’s Contribution to Faster Trials
The landscape of clinical trials is continually evolving, becoming more intricate and demanding than ever before. This evolution brings with it a significant increase in the costs associated with running these trials. Amid this dynamic environment, enhancing the Probability of Success (POS) and, most importantly, accelerating time-to-market for each development have emerged as crucial objectives for…